Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/03/2005US20050244931 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244929 Expression of functional antibody fragments
11/03/2005US20050244928 Method of producing recombinant proteins
11/03/2005US20050244927 Process for producing polypeptides
11/03/2005US20050244926 Polypeptide which acts on fructosyl valyl histidine to produce alpha-ketoaldehyde, valyl histidine and hydrogen peroxide; stability; use as enzyme for diagnosis
11/03/2005US20050244925 Proteases from gram-positive organisms
11/03/2005US20050244924 Methods and constructs for high yield expression of clostripain
11/03/2005US20050244923 from Stachybotrys parvispora with specific amino acid sequence; useful in modifying the color associated with dyes and colored compounds, as well as in anti-dye transfer during fabric washing; novel phenol oxidizing enzymes; for stain bleaching or anti dye transfer; amino acid and nucleic acid sequences
11/03/2005US20050244922 Bacillus host cell
11/03/2005US20050244921 Fluorescent protein variants and methods for making same
11/03/2005US20050244920 Protein synthesis system using xenopus oocyte extract
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244901 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244887 Nucleic acid amplification reaction station for disposable test devices
11/03/2005US20050244882 Isolation of nucleic acids on surfaces
11/03/2005US20050244880 Cellular arrays and methods of detecting and using genetic disorder markers
11/03/2005US20050244878 BGL5 beta-glucosidase and nucleic acids encoding the same
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244876 Human tumor necrosis factor receptors TR13 and TR14
11/03/2005US20050244875 Sequencing preferential nucleotide sequences; obtain nucleotide sequences, insert preferential heavy elements into compound, insert into microscope, monitor base preferential labels, determine nucleotide sequence
11/03/2005US20050244871 Polynucleotide probe having enhanced binding specificity, microarray having the probe immobilized thereon, and method of designing the probe
11/03/2005US20050244869 Modulation of transthyretin expression
11/03/2005US20050244867 Growth factor HTTER36
11/03/2005US20050244862 Identification of ligands by selective amplification of cells transfected with receptors
11/03/2005US20050244861 Nucleic acids essential for expression of hyphal-specific genes and methods for using the same
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244858 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/03/2005US20050244857 Death domain containing receptor 4
11/03/2005US20050244856 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
11/03/2005US20050244855 Novel human kinase proteins and polynucleotides encoding the same
11/03/2005US20050244854 Novel method for the identification of clones conferring a desired biological property from an expression library
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244845 90 human secreted proteins
11/03/2005US20050244842 Promoter sequences
11/03/2005US20050244841 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/03/2005US20050244832 Class II cytokine receptor-7
11/03/2005US20050244831 Target dna
11/03/2005US20050244827 Method
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244825 Regulation of human bmp-2 inducible kinase
11/03/2005US20050244824 Method of assaying target nucleic acid and kit therefor
11/03/2005US20050244822 Method of monitoring gene expression
11/03/2005US20050244819 Assay system for screening protease inhibitors
11/03/2005US20050244818 Single cell analysis of HIV replication capacity and drug resistance
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244806 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
11/03/2005US20050244505 Immunotherapy compositions, method of making and method of use thereof
11/03/2005US20050244504 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters)
11/03/2005US20050244437 Live antenuated parasite vaccine
11/03/2005US20050244436 Combination Neisserial compositions
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244434 Tat-based tolerogen compositions and methods of making and using same
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244431 Recombinant herpesvirus and polyvalent vaccine
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244429 Live replicating spumavirus vector
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244415 administering an antibody which recognizes an extracellular domain of signal regulatory protein-beta (SIRP-beta); treatment of infections or cancer
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244409 Erythropoietin receptor antibodies
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244400 Acid alpha-glucosidase and fragments thereof
11/03/2005US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050244377 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
11/03/2005US20050244376 Modified viral surface proteins for binding to extracellular matrix components
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050244333 That combine a binding site recognizing the same epitope as T84.66 and a polypeptide framework of a human or humanized antibody; exhibit binding affinity and specificity for carcinoembryonic antigen nearly identical to that of T84.66 and the ability to specifically target tumors expressing CEA
11/03/2005DE102004017410A1 Mortar comprising shaft and glass tip with rough surface, useful for grinding chitin-containing structures, especially for extraction of DNA from insects
11/03/2005CA2605574A1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005CA2564594A1 Generation of plants with altered oil content
11/03/2005CA2563943A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants
11/03/2005CA2563875A1 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
11/03/2005CA2563874A1 Erythropoietin protein variants
11/03/2005CA2563754A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005CA2563741A1 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005CA2563614A1 Tlr ligand and il-1 response-injured animal model
11/03/2005CA2562833A1 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/03/2005CA2562674A1 Rnai-based target identification and validation
11/03/2005CA2562673A1 Universal target sequences for sirna gene silencing
11/03/2005CA2562548A1 Expression of fatty acid desaturases in corn
11/03/2005CA2561706A1 Truncated adamts molecules
11/03/2005CA2561691A1 Method of constructing recombinant herpes simplex virus
11/03/2005CA2561145A1 Methods for controlling plant pathogens using n-phosphonomethylglycine
11/03/2005CA2560074A1 Combinatorial protein library screening by periplasmic expression
11/03/2005CA2559481A1 Corn event mir604
11/03/2005CA2559228A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005CA2557175A1 Novel alcohol dehydrogenases
11/02/2005EP1591774A1 Apparatus and method for the detection of biomolecules
1 ... 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 ... 4023